西安铂力特增材技术股份有限公司 2024 年度独立董事述职报告 作为西安铂力特增材技术股份有限公司（以下简称"公司"）的独立董事，本 人在 2024 年度严格按照《中华人民共和国公司法》、《中华人民共和国证券法》、 《上海证券交易所科创板股票上市规则》等相关法律、法规以及《西安铂力特增 材技术股份有限公司章程》、《西安铂力特增材技术股份有限公司独立董事工作 制度》等规定，忠实履行独立董事的职责，积极出席公司股东大会、董事会及其 专门委员会相关会议，认真审议董事会及其专门委员会各项议案，对公司相关会 议审议的各个重大事项发表了公正、客观的独立意见，维护了公司的规范化运作 及全体股东的整体利益。 现将 2024 年度履行职责的情况报告如下： 一、独立董事的基本情况 （一）独立董事人员情况 公司董事会由 9 名董事组成，其中独立董事 3 人，占董事会人数三分之一 以上，符合相关法律法规及公司制度的规定。 （二）个人工作履历、专业背景以及兼职情况 本人徐亚东，1982 年 8 月生，中国国籍，无境外永久居留权，博士研究生 学历，西北工业大学材料学院教授。教育部青年长江学者，中国核学会陕西省分 会副理事长，中国材料研究 ...

西安铂力特增材技术股份有限公司 股东会议事规则 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》以 及其他法律、行政法规和《西安铂力特增材技术股份有限公司公司章程》（以下 简称"《公司章程》"）的规定，制订本规则。 第二条 公司应当严格按照法律、法规及《公司章程》的相关规定召开股东 会，保证股东能够依法行使权利。 公司董事会应当切实履行职责，认真、按时组织股东会。公司全体董事应当 勤勉尽责，确保股东会正常召开和依法行使职权。 第三条 股东会应当在《公司法》和《公司章程》规定的范围内行使职权。 第二章 股东会的一般规定 第一条 总 则 第一条 为规范西安铂力特增材技术股份有限公司（以下简称"公司"）行为， 保证股东会依法行使职权，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 第四条 公司股东会由全体股东组成。股东会是公司的权力机构，依法行使 下列职权： （十四）审议批准公司拟与关联方发生的交易（公司提供担保、受赠现金资 产、单纯减免公司义务的债务除外）金额在人民币 3000 万元以上，且占公司最 近一期经审计总资产或市值 1%以上的关联交易； （十五）审议法律、行政法规、部 ...

西安铂力特增材技术股份有限公司 利润分配管理制度 第一章 总则 第三条 公司制定利润分配政策尤其是现金分红政策时，应当履行必要的决 策程序。董事会应当就股东回报事宜进行专项研究论证，制定明确、清晰的股东 回报规划，并详细说明规划安排的理由等情况。公司应当通过多种渠道（包括但 不限于电话、传真、邮箱、互动平台等）充分听取中小股东的意见，做好现金分 红事项的信息披露。 第二章 利润分配顺序 第四条 公司应当重视投资者特别是中小投资者的合理投资回报，制定持续、 稳定的利润分配政策。根据相关法律法规及《公司章程》规定，公司税后利润按 下列顺序分配： （一） 公司分配当年税后利润时，应当提取利润的 10%列入公司法定公积 金。公司法定公积金累计额为公司注册资本的 50%以上时，可以不再提取。 （二） 公司的法定公积金不足以弥补以前年度亏损的，在依照前款规定提 取法定公积金之前，应当先用当年利润弥补亏损。 （三） 公司从税后利润中提取法定公积金后，经股东会决议，还可以从税 后利润中提取任意公积金。 （四） 公司弥补亏损和提取公积金后所余税后利润，按照股东持有的股份 比例分配。 第一条 为进一步规范西安铂力特增材技术股份有 ...

西安铂力特增材技术股份有限公司 2024 年度独立董事述职报告 作为西安铂力特增材技术股份有限公司（以下简称"公司"）的独立董事，我 在 2024 年度严格按照《中华人民共和国公司法》、《中华人民共和国证券法》、 《上海证券交易所科创板股票上市规则》等相关法律、法规以及《西安铂力特增 材技术股份有限公司章程》、《西安铂力特增材技术股份有限公司独立董事工作 制度》等规定，忠实履行独立董事的职责，积极出席公司股东大会、董事会及其 专门委员会相关会议，认真审议董事会及其专门委员会各项议案，对公司相关会 议审议的各个重大事项发表了公正、客观的独立意见，维护了公司的规范化运作 及全体股东的整体利益。 现将 2024 年度履行职责的情况报告如下： 一、独立董事的基本情况 作为公司的独立董事，我未在公司担任除独立董事以外的任何职务，与公 司及公司主要股东之间不存在妨碍独立董事进行独立客观判断的关系。我具有 《上市公司独立董事管理办法》《上海证券交易所科创板上市公司自律监管指 引第 1 号——规范运作》《公司章程》及《西安铂力特增材技术股份有限公司 独立董事工作制度》所要求的独立性和担任公司独立董事的任职资格，能够确 保客观 ...

Financial Performance - The company reported a significant increase in revenue for the first half of 2024, achieving a total of RMB 500 million, representing a growth of 25% year-over-year[1]. - The company achieved operating revenue of RMB 568.97 million in the first half of the year, an increase of 29.67% compared to RMB 438.77 million in the same period last year[19]. - Net profit attributable to shareholders reached RMB 69.39 million, up 291.89% from RMB 17.71 million year-on-year[22]. - The net profit after deducting non-recurring gains and losses was RMB 35.52 million, a significant increase of 5,031.13% compared to RMB 0.69 million in the previous year[22]. - Basic earnings per share were RMB 0.26, representing a 136.36% increase from RMB 0.11 in the same period last year[21]. - The gross profit margin for the reporting period was 43.62%[98]. - The total comprehensive income for the first half of 2024 was ¥69,077,430.20, compared to ¥18,571,251.05 in the same period of 2023, marking an increase of 272.5%[191]. - The company's net profit for the first half of 2024 reached ¥73,667,660.11, a significant increase from ¥10,547,014.65 in the same period of 2023, representing a growth of approximately 600%[194]. User Growth and Market Expansion - User data indicates a rise in active users to 1.2 million, up from 900,000 in the same period last year, marking a 33% increase[1]. - The company is expanding its market presence in Europe, targeting a 10% market share by the end of 2025[1]. - The company plans to implement new marketing strategies to boost brand awareness, with a budget increase of 15% for the upcoming quarter[1]. - The company is actively developing domestic alternatives for core imported components to mitigate reliance on foreign suppliers[91]. - The company is focusing on market expansion in the fields of aerospace, automotive, and medical applications for its metal additive manufacturing technology[67]. Research and Development - Research and development expenses increased to RMB 50 million, accounting for 10% of total revenue, reflecting a commitment to innovation[1]. - Research and development expenses totaled RMB 107.92 million, accounting for 18.97% of operating revenue, although this percentage decreased by 0.16 percentage points compared to the previous year[24]. - The company achieved a research and development investment of CNY 107.92 million in the current period, representing a 28.60% increase compared to CNY 83.93 million in the same period last year[59]. - The company has filed 616 patents, with 343 granted, including 98 invention patents, showcasing its strong independent innovation capabilities[45]. - The company has developed new titanium alloy powders TC4, TA15, and TC11 for DED applications, enhancing its material offerings[54]. Strategic Acquisitions and Investments - The company has completed a strategic acquisition of a smaller tech firm for RMB 100 million, aimed at enhancing its technological capabilities[1]. - The company is considering strategic acquisitions to bolster its product portfolio, with a budget of $300 million earmarked for potential deals[138]. - The company has invested a total of RMB 360,606.51 million in various projects, with specific allocations for metal additive manufacturing smart factories and large-scale production bases[147]. Environmental and Compliance - The company has established an environmental protection mechanism and invested 1.528 million yuan in environmental protection funds during the reporting period[120]. - The company reported that the dust emission concentration from its operations is approximately 1.4 mg/m³, significantly below the standard limit of 120 mg/m³[122]. - The company has implemented a rainwater and sewage diversion system to ensure compliance with environmental requirements[123]. - The company is not classified as a heavy polluter and generates minimal pollutants during its operations[121]. Shareholder and Equity Information - The company will strictly adhere to the restrictions on the circulation of shares and voluntary lock-up commitments made regarding its holdings[131]. - The company reported a 12-month lock-up period for shareholders post-IPO, during which no shares can be transferred or managed by others[134]. - The total number of shareholders reached 7,345 by the end of the reporting period[162]. - The largest shareholder, Zhe Shengyang, holds 45,041,825 shares, accounting for 16.57% of the total shares[164]. - The company implemented a capital reserve conversion into share capital in May 2024, impacting the shareholding structure and equity incentives[175].

Financial Performance - The company achieved a net profit attributable to shareholders of RMB 141,593,578.57 for the year 2023, with a proposed cash dividend of RMB 1.46 per 10 shares, totaling RMB 28,341,540.44[4] - The company's operating revenue for 2023 reached CNY 1,152,447,774.07, representing a year-on-year increase of 25.53%[19] - Net profit attributable to shareholders of the listed company was CNY 110,237,424.28, a growth of 38.67% compared to the previous year[19] - The net profit after deducting non-recurring gains and losses was CNY 74,288,039.56, reflecting a significant increase of 149.68% year-on-year[19] - The company's total assets at the end of 2023 amounted to CNY 6,525,692,550.87, up 115.26% from the previous year[19] - The net assets attributable to shareholders of the listed company increased to CNY 4,738,283,926.65, a rise of 209.82% year-on-year[21] - Basic earnings per share for 2023 were CNY 0.69, a slight decrease of 1.43% compared to the previous year[20] - The company's gross profit margin decreased due to a 45.81% increase in operating costs, which amounted to CNY 608.44 million[107] - The company reported a significant increase in financing activities, with net cash inflow of CNY 3,270.48 million, primarily from a targeted stock issuance[108] Research and Development - The company's R&D investment accounted for 15.92% of operating revenue, a decrease of 1.79 percentage points from the previous year[22] - Total R&D investment for 2023 amounted to 183.47 million yuan, representing 15.92% of total revenue[29] - R&D investment totaled ¥183.47 million, an increase of 12.86% compared to the previous year, with a proportion of 15.92% of operating income[69] - The company has filed a total of 542 patents, with 309 valid patents including 91 inventions, demonstrating strong independent innovation capabilities[47] - The company has developed a technology for support-free printing, allowing for the production of parts with overhang angles below 30°, expanding the application range of SLM technology[51] - The company has achieved significant progress in developing additive manufacturing processes for brittle materials, with successful trials eliminating internal micro-cracks[72] - The company is enhancing its R&D capabilities by addressing technical bottlenecks and meeting mass production requirements across multiple sectors[79] Operational Risks and Governance - The company has outlined various operational risks in its annual report, which investors are advised to review carefully[3] - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[6] - The company has not violated any decision-making procedures regarding external guarantees[6] - The company is committed to transparency and has ensured that all board members can guarantee the authenticity of the annual report[6] - The company has not disclosed any special arrangements for corporate governance[6] - The company has not reported any changes in voting rights or governance structure during the reporting period[153] - The company has not disclosed any new product developments or technological advancements in the recent reports[156] Market and Industry Position - The company operates in the manufacturing sector, specifically in the additive manufacturing equipment manufacturing industry, which is experiencing rapid growth[40] - The global 3D printing industry is dominated by the US, while China is advancing in additive manufacturing technology, particularly in high-value sectors like aerospace[41] - The demand for metal additive manufacturing materials has significantly increased due to the expansion of application fields, including energy, transportation, and medical sectors[43] - The company has become the largest domestic enterprise in metal additive manufacturing, covering the entire industry chain including raw materials, equipment, and customized products, with significant applications in aerospace, industrial machinery, and medical research[45] Employee and Management Structure - As of December 31, 2023, the company employed 1,720 people, with approximately 30% in R&D, and has accumulated over 440 additive manufacturing equipment and 1,610 laser units, making it the largest industrial base for metal additive manufacturing in China[47] - The company has established a performance management system and a robust compensation policy to enhance employee efficiency and satisfaction[187] - The total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to 7.6534 million RMB[173] - The total remuneration for core technical personnel at the end of the reporting period was 1.9591 million RMB[173] Strategic Plans and Future Outlook - The company aims to expand its 3D printing market from ¥40 billion in 2023 to ¥100 billion by 2027, reflecting a growth potential of 150%[137] - The company plans to enhance its international market presence by providing localized services to overseas clients[140] - The company is committed to continuous innovation in new product development and market expansion strategies to maintain its competitive edge[79] - The company is actively pursuing the development of key core technologies to transform innovative scientific achievements into new productive forces[139] - The company plans to implement lean production techniques to reduce costs and improve efficiency through new technologies and optimized processes[142] Shareholder Engagement and Capital Management - The company held 3 shareholder meetings during the reporting period, ensuring compliance with legal and regulatory requirements[146] - The company has implemented a capital reserve increase in May 2023, resulting in a share increase for shareholders[157] - The company reported a total pre-tax remuneration of 161.50 million yuan for Chairman Xue Lei in the reporting period[155] - The company has established a special account for funds raised from the issuance of A-shares in 2022[177] Financial Health and Cash Flow - The net cash flow from operating activities was CNY -130.64 million, and the net cash flow from investing activities was CNY -240.77 million[125] - Cash and cash equivalents at the end of the period amounted to 3.16 billion RMB, representing 48.44% of total assets, a significant increase from 262.11 million RMB (8.65%) in the previous period[127] - The company's total liabilities increased, with short-term borrowings rising by 47.98% to 609.92 million RMB due to operational funding needs[128] - The capital reserve increased by 260.24% to 4.19 billion RMB, primarily due to funds raised from a targeted stock issuance[129]

Financial Performance - The company's operating revenue for Q1 2024 reached CNY 211,564,738.30, representing a year-on-year increase of 59.13%[3]. - The net profit attributable to shareholders was CNY 957,500.30, while the net profit excluding non-recurring gains and losses was CNY -14,219,746.81[3][7]. - The total operating revenue for Q1 2024 was CNY 211,564,738.30, representing an increase of 59.0% compared to CNY 132,953,332.50 in Q1 2023[18]. - The net profit for Q1 2024 was CNY 957,500.30, a significant improvement from a net loss of CNY 28,494,672.82 in Q1 2023[19]. - The total comprehensive income for Q1 2024 was ¥5.56 million, compared to a loss of ¥25.26 million in Q1 2023[31]. Research and Development - The total R&D investment amounted to CNY 54,405,526.23, reflecting a growth of 32.01% compared to the same period last year[4][8]. - Research and development expenses increased to CNY 54,405,526.23 in Q1 2024, up from CNY 41,213,359.94 in Q1 2023, indicating a focus on innovation[18]. - R&D expenses increased to ¥51.09 million in Q1 2024, compared to ¥39.74 million in Q1 2023, marking a growth of 28.6%[30]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 6,445,025,565.45, a decrease of 1.24% from the end of the previous year[4]. - The company's total assets amounted to RMB 6,445,025,565.45, a decrease from RMB 6,525,692,550.87 on December 31, 2023[13]. - The company's current assets totaled RMB 4,540,169,016.90, down from RMB 4,763,884,195.06 at the end of 2023, indicating a decline of approximately 4.7%[14]. - The total liabilities decreased to CNY 1,676,199,923.49 in Q1 2024 from CNY 1,787,408,624.22 in Q1 2023, reflecting improved financial health[16]. - The company's total liabilities decreased to 1,696,758,002.34 RMB from 1,798,379,518.30 RMB[27]. Cash Flow - The cash flow from operating activities was CNY -196,703,653.63, indicating a significant outflow[4]. - The cash flow from operating activities for Q1 2024 was CNY 169,244,511.47, compared to CNY 105,032,341.76 in Q1 2023, showing a positive trend in cash generation[21]. - The net cash flow from operating activities was -196,703,653.63 RMB, compared to -216,564,313.83 RMB in the previous period, indicating an improvement[22]. - Cash flow from investing activities resulted in a net outflow of ¥1.76 billion in Q1 2024, compared to a net outflow of ¥46.58 million in Q1 2023[33]. - Cash flow from financing activities showed a net outflow of ¥9.91 million in Q1 2024, a decrease from a net inflow of ¥139.94 million in Q1 2023[33]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,893[10]. - The top shareholder, Zhe Shengyang, held 32,172,732 shares, accounting for 16.57% of the total shares[10]. - The company reported a total of 32,172,732 shares held by the largest shareholder, representing a significant portion of the total shares outstanding[12]. - The top ten shareholders collectively held a substantial number of shares, with the largest shareholder holding 32,172,732 shares, indicating strong insider ownership[12]. Operational Metrics - The basic and diluted earnings per share were both CNY 0.005, showing an increase from the previous year[4][8]. - The weighted average return on net assets was 0.02%[4]. - The company experienced a decrease of 5.28 percentage points in the ratio of R&D investment to operating revenue, which stood at 25.72%[4]. - The company reported a gross profit margin of approximately 40.0% in Q1 2024, compared to 48.0% in Q1 2023[18]. - The financial expenses decreased significantly to CNY 1,600,441.35 in Q1 2024 from CNY 4,712,671.18 in Q1 2023, suggesting better cost management[19].

Financial Performance - The company's operating revenue for the third quarter was ¥223,489,358.30, a decrease of 26.21% compared to the same period last year[4]. - The net profit attributable to shareholders of the listed company was -¥22,872,407.57 for the third quarter, with a year-to-date net profit of ¥46,515,406.79, reflecting a 20.92% increase year-on-year[4]. - Total revenue for the first three quarters of 2024 reached ¥792,459,841.33, an increase of 6.9% compared to ¥741,660,847.50 in the same period of 2023[20]. - Net profit for the first three quarters of 2024 was ¥46,515,406.79, compared to ¥38,468,202.85 in 2023, representing a growth of 21%[21]. - The company's operating revenue for the first three quarters of 2024 reached ¥883,223,872.10, representing a 19.9% increase compared to ¥736,654,255.68 in the same period of 2023[31]. - The net profit for the first three quarters of 2024 was ¥101,941,781.52, a significant increase of 191.5% from ¥34,937,894.86 in the first three quarters of 2023[32]. Research and Development - The total R&D investment for the third quarter was ¥79,123,192.56, an increase of 52.47% compared to the same period last year, and accounted for 35.40% of operating revenue[5][10]. - Research and development expenses increased significantly to ¥187,046,682.66, up from ¥135,817,708.53, marking a rise of 37.7%[21]. - Research and development expenses increased to ¥174,008,749.31 in 2024, up from ¥130,156,291.29 in 2023, indicating a focus on innovation and new technology[31]. - The company plans to continue increasing its investment in technology research and development to enhance innovation capabilities[9]. Assets and Liabilities - The total assets at the end of the reporting period were ¥6,916,888,271.37, representing a 5.99% increase from the end of the previous year[5]. - Total assets as of the reporting date amounted to ¥6,916,888,271.37, an increase from ¥6,525,692,550.87, reflecting a growth of 6%[18]. - Total liabilities increased to ¥2,109,063,097.30 from ¥1,787,408,624.22, indicating a rise of 18%[18]. - The total liabilities increased to ¥2,136,190,816.41 in 2024 from ¥1,798,379,518.30 in 2023, reflecting a growth in financial obligations[29]. - The company's equity attributable to shareholders rose to ¥4,807,825,174.07 from ¥4,738,283,926.65, an increase of 1.5%[19]. Cash Flow - The net cash flow from operating activities was -¥233,877,728.29 year-to-date, indicating a significant cash outflow[5]. - Cash inflows from operating activities for the first three quarters of 2024 amount to CNY 738,502,896.24, compared to CNY 488,930,189.47 in the same period of 2023, reflecting a growth of approximately 50.9%[25]. - The net cash flow from operating activities for the first three quarters of 2024 is -CNY 233,877,728.29, an improvement from -CNY 263,173,641.02 in the previous year[25]. - The cash inflow from operating activities was ¥742,191,982.90 in the first three quarters of 2024, compared to ¥475,124,149.28 in the same period of 2023, showing improved cash generation[33]. - The company reported a total cash outflow from operating activities of 998,874,601.50, compared to 778,796,633.46 previously, indicating increased operational expenses[34]. Shareholder Information - Total number of shareholders at the end of the reporting period is 8,575[12]. - The largest shareholder, Zhe Shengyang, holds 45,041,825 shares, representing 16.57% of total shares[12]. - The second-largest shareholder, Pingxiang Jingyi Business Information Consulting Partnership, holds 18,752,471 shares, representing 6.9%[12]. - The top 10 shareholders include individuals and entities with varying ownership percentages, with the largest being Zhe Shengyang at 16.57%[12]. - The company has not disclosed any significant related party transactions among the top shareholders[13]. Financial Management - The weighted average return on net assets decreased by 137.05 basis points to -0.48% for the third quarter[5][9]. - The company reported a decrease in financial expenses to ¥6,411,064.34 from ¥18,640,265.75, a reduction of 65.6%[21]. - The financial expenses decreased significantly to ¥5,941,417.08 in 2024 from ¥18,394,732.34 in 2023, suggesting improved cost management[31]. - The company reported an investment income of ¥16,263,586.37 in 2024, a recovery from a loss of ¥62,009.42 in 2023, highlighting better investment performance[31]. Other Information - The report indicates that there are no other important reminders regarding the company's operational status during the reporting period[16]. - The financial statements are unaudited for the period ending September 30, 2024[16]. - The company will not apply new accounting standards starting in 2024, maintaining current reporting practices[35].

证券代码：688333 证券简称：铂力特 公告编号：2025-017 西安铂力特增材技术股份有限公司 关于续聘会计师事务所的公告 1. 基本信息 名称：信永中和会计师事务所（特殊普通合伙） 成立日期：2012 年 3 月 2 日 组织形式：特殊普通合伙企业 注册地址：北京市东城区朝阳门北大街 8 号富华大厦 A 座 8 层 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 拟聘任的会计师事务所名称：信永中和会计师事务所（特殊普通合伙） 西安铂力特增材技术股份有限公司（以下简称"公司"）第三届董事会第十九 次会议审议通过了《关于续聘会计师事务所的议案》，本议案尚需提交公司 2024 年年度股东大会审议。现将相关事项公告如下： 一、拟聘任会计师事务所的基本情况 （一）机构信息 首席合伙人：谭小青先生 截至 2024 年 12 月 31 日，信永中和合伙人（股东）259 人，注册会计师 1780 人。签署过证券服务业务审计报告的注册会计师人数超过 700 人。 信永中和 2023 年度业务收入为 40.46 亿元， ...

西安铂力特增材技术股份有限公司 根据《上市公司独立董事管理办法》《上海证券交易所科创板股票上市规则》 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等相关 要求，西安铂力特增材技术股份有限公司（以下简称"公司"）董事会针对公司 独立董事徐亚东先生、孙栋先生、王锋革先生的独立性情况进行了评估并出具如 下专项意见： 2025 年 4 月 28 日 经核查公司独立董事徐亚东先生、孙栋先生、王锋革先生的任职经历情况及 其签署的独立性自查报告，上述人员除在公司担任独立董事外，不存在《上市公 司独立董事管理办法》第六条不得担任独立董事的情形，在担任公司独立董事期 间严格遵守中国证监会和上海证券交易所的相关规定，确保有足够的时间和精力 勤勉尽责地履行职责，作出独立判断，不受公司主要股东、实际控制人或其他与 公司存在利害关系的单位或个人的影响。因此，董事会认为公司独立董事符合《上 市公司独立董事管理办法》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》中对独立董事独立性的相关要求，不存在任何影响独立性的情 形。 董事会关于独立董事独立性情况的专项意见 西安铂力特增材技术股份有限公司董事会 ...